Demetrios Braddock, MD, PhD
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Demetrios Braddock was born in Tennessee, educated at the University of Chicago, trained at the NIH in Anatomic Pathology and Biophysical Chemistry, and came to Yale in 2004 where he practices hematopathology and heads a laboratory studying pathogenic mechanisms of severe and poorly addressed human diseases. His laboratory focuses on rare diseases of children, and on the design and engineering of novel biologics to modulate disease outcomes.
Work in Dr. Braddock’s laboratory includes the design and validation of an enzyme biologic for a lethal infantile calcification disorder called ‘Generalized Arterial Calcification of Infancy’ (GACI), which has been translated into patients and is now in clinical trials in infants, children, and adults with GACI, ARHR2, PXE, and CKD-MBD (ClinicalTrials.gov: NCT05734196, NCT06046820, NCT04686175, NCT06283589).
Education & Training
- FellowYale University School of Medicine (2010)
- ResidentNational Cancer Institute, NIH, Laboratory of Pathology (2000)
- MDUniversity of Chicago Pritzker School of Medicine (1996)
- PhDUniversity of Chicago (1994)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Yale 2022 Faculty Innovation Award | Yale University | 2022 |
Departments & Organizations
- Biochemistry, Quantitative Biology, Biophysics and Structural Biology (BQBS)
- Braddock Lab
- Dean's Workshops
- Discovery to Cure Internship
- Genomics, Genetics, and Epigenetics
- Hematopathology
- Hematopathology
- Molecular Medicine, Pharmacology, and Physiology
- Pathology
- Pathology and Molecular Medicine
- Pathology Research
- Program in Translational Biomedicine (PTB)
- Prostate & Urologic Cancers Program
- Structural Biology
- Surgical Pathology
- Vascular Biology and Therapeutics Program
- Yale Cancer Center
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Medicine
- Yale Ventures